Sign Up to like & get
recommendations!
0
Published in 2017 at "Disease Markers"
DOI: 10.1155/2017/7075935
Abstract: Aim. To determine whether nucleot(s)ide analogs therapy has survival benefit for patients with HBV-related HCC after unresectable treatment. Method. A systematic search was conducted through seven electronic databases including PubMed, OVID, EMBASE, Cochrane Databases, Elsevier,…
read more here.
Keywords:
nucleot ide;
hbv related;
group;
analogs therapy ... See more keywords